tradmap

MPT Earnings Medical Properties Trust Inc

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$4 -$1 $3 $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $772M $2B 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$2B -$697M $1B $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$1 -$1 $0 $0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
EPS
Revenue (quarterly)
-$122M $108M $337M $0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
Revenue
Net income (quarterly)
-$876M -$379M $117M $0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25
Net income

Reported EPS history

1–60 of 60
Q1 20262026-03-310.052026-05-0810-Q
Q4 2025 (derived)2025-12-310.032026-02-2610-K
FY 20252025-12-31-0.462026-02-2610-K
Q3 20252025-09-30-0.132025-11-0710-Q
Q2 20252025-06-30-0.162025-08-0810-Q
Q1 20252025-03-31-0.202025-05-0910-Q
Q4 2024 (derived)2024-12-31-0.682025-03-0310-K
FY 20242024-12-31-4.022025-03-0310-K
Q3 20242024-09-30-1.342024-11-1210-Q
Q2 20242024-06-30-0.542024-08-0910-Q
Q1 20242024-03-31-1.462024-05-2910-Q
Q4 2023 (derived)2023-12-31-1.102024-02-2910-K
FY 20232023-12-31-0.932024-02-2910-K
Q3 20232023-09-300.192023-11-0910-Q
Q2 20232023-06-30-0.072023-08-0910-Q
Q1 20232023-03-310.052023-05-1010-Q
Q4 2022 (derived)2022-12-31-0.242023-03-0110-K
FY 20222022-12-311.502023-03-0110-K
Q3 20222022-09-300.372022-11-0910-Q
Q2 20222022-06-300.322022-08-0910-Q
Q1 20222022-03-311.05——
FY 20212021-12-311.11——
Q3 20212021-09-300.29——
Q2 20212021-06-300.19——
FY 20202020-12-310.812021-03-0110-K
Q4 20192019-12-310.262020-02-2710-K
FY 20192019-12-310.872020-02-2710-K
Q3 20192019-09-300.202019-11-1210-Q
Q2 20192019-06-300.20——
Q1 20192019-03-310.20——
Q4 20182018-12-310.212019-03-0110-K
FY 20182018-12-312.762019-03-0110-K
Q3 20182018-09-302.002018-11-0910-Q
Q2 20182018-06-300.30——
Q1 20182018-03-310.25——
Q4 20172017-12-310.192018-03-0110-K
FY 20172017-12-310.822018-03-0110-K
Q3 20172017-09-300.212017-11-0910-Q
Q2 20172017-06-300.212017-08-0910-Q
Q1 20172017-03-310.21——
Q4 20162016-12-310.132017-03-0110-K
FY 20162016-12-310.862017-03-0110-K
Q3 20162016-09-300.282016-11-0910-Q
Q2 20162016-06-300.222016-08-0910-Q
Q1 20162016-03-310.242016-05-1010-Q
Q4 20152015-12-310.242016-02-2910-K
FY 20152015-12-310.632016-02-2910-K
Q3 20152015-09-300.10——
Q2 20152015-06-300.11——
Q1 20152015-03-310.172015-05-1110-Q
Q4 20142014-12-310.082015-03-0210-K
FY 20142014-12-310.292015-03-0210-K
Q3 20142014-09-300.162014-11-1010-Q
Q1 20142014-03-310.042014-05-1210-Q
Q4 20132013-12-310.112014-03-0310-K
FY 20132013-12-310.632014-03-0310-K
Q3 20132013-09-300.162013-11-0810-Q
Q2 20132013-06-300.182013-08-0910-Q
Q1 20132013-03-310.182013-05-1010-Q
Q4 20122012-12-310.212013-02-2210-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.